In several patients after Qutiro infusion, chills, chest pain and convulsions occurred; blood cultures grew Klebsiella pneumoniae ESBL. A microbiological contamination of the sterile infusion product is suspected, posing a real threat to patients’ health or life. Potential effects: severe bloodstream infection, septic shock, life‑threatening complications.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use the product from batch GL23G-03. Healthcare facilities should immediately withdraw this batch from use, separate it from other stocks, and monitor patients who received the drug, reporting ...
The Chief Pharmaceutical Inspector suspended distribution of Qutiro 5mg/100ml batch GL23G-03 throughout the country, granted the decision immediate enforceability, and obliged the company to take acti...
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related